Michael Collins is a seasoned professional with over 15 years of experience in global R&D, specializing in project and portfolio management. They have held key positions at prominent organizations, including serving as the Global Head of Research and Development Project Management at CSL Behring since 2022, and previously as a Global Project and Portfolio Management Leader at Roche from 2015 to 2021. Michael's career also includes leadership roles at Novartis, Fujisawa, and MediGene AG, where they drove strategic transformation and innovation in drug development. They earned their degree from the University of Limerick, completing their studies in 1997.
This person is not in any teams
This person is not in any offices